Compare TNON & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNON | PAVM |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 8.5M |
| IPO Year | 2022 | 2016 |
| Metric | TNON | PAVM |
|---|---|---|
| Price | $0.98 | $6.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $510.00 |
| AVG Volume (30 Days) | ★ 77.5K | 27.6K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,233,000.00 | $29,000.00 |
| Revenue This Year | $19.56 | N/A |
| Revenue Next Year | $71.06 | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $6.00 |
| 52 Week High | $5.85 | $26.85 |
| Indicator | TNON | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 65.45 |
| Support Level | $0.94 | $6.26 |
| Resistance Level | $1.03 | $9.28 |
| Average True Range (ATR) | 0.05 | 0.88 |
| MACD | 0.00 | 0.30 |
| Stochastic Oscillator | 39.07 | 72.11 |
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.